Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG(L)-scFv) (IGLFV-180)

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-M2 antibody are fused to the C terminus of an anti-TCR (Vβ8) IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can retarget T cells to virus-infected cells. It is designed for the research of Inﬂuenza virus infection therapy.

Datasheet INQUIRY

Specifications

Targets

M2 & TCR (Vβ8)

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inﬂuenza virus infection

Targets

Target 1

Gene ID

956528

UniProt ID

P03428

Alternative Names

influenza virus M2 protein;M2

Target 2

TCR (Vβ8)

Gene ID

28588

Alternative Names

Trbv8; T cell receptor beta variable 8; TCR; T-cell receptor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG(L)-scFv) (IGLFV-180). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-M2 x Anti-TCR (Vβ8) Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-180)

Specifications

Targets

Customer Reviews and Q&As